Ranibizumab in patients with neovascular age-related macular degeneration in real-world clinical settings in France: 1-year data from the LUMINOUS (TM) study - Université de Bourgogne Accéder directement au contenu
Communication Dans Un Congrès Année : 2016

Ranibizumab in patients with neovascular age-related macular degeneration in real-world clinical settings in France: 1-year data from the LUMINOUS (TM) study

Mots clés

Fichier non déposé

Dates et versions

hal-01549028 , version 1 (28-06-2017)

Identifiants

  • HAL Id : hal-01549028 , version 1

Citer

Vittorio Capuano,, Benjamin Wolff, Salomon-Yves Cohen, Catherine P Creuzot-Garcher, Jean-Francois Korobelnik, et al.. Ranibizumab in patients with neovascular age-related macular degeneration in real-world clinical settings in France: 1-year data from the LUMINOUS (TM) study. Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology (ARVO), May 2016, Seattle, United States. ⟨hal-01549028⟩
202 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More